These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25921551)

  • 1. Modafinil combined with cognitive training: pharmacological augmentation of cognitive training in schizophrenia.
    Michalopoulou PG; Lewis SW; Drake RJ; Reichenberg A; Emsley R; Kalpakidou AK; Lees J; Bobin T; Gilleen JK; Pandina G; Applegate E; Wykes T; Kapur S
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1178-89. PubMed ID: 25921551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial.
    Gilleen J; Michalopoulou PG; Reichenberg A; Drake R; Wykes T; Lewis SW; Kapur S
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):529-39. PubMed ID: 24485800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
    Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
    J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Lees J; Michalopoulou PG; Lewis SW; Preston S; Bamford C; Collier T; Kalpakidou A; Wykes T; Emsley R; Pandina G; Kapur S; Drake RJ
    Psychol Med; 2017 Oct; 47(13):2358-2368. PubMed ID: 28464963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
    Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; Walsh JP; Goff DC
    J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    Pierre JM; Peloian JH; Wirshing DA; Wirshing WC; Marder SR
    J Clin Psychiatry; 2007 May; 68(5):705-10. PubMed ID: 17503979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.
    Arbabi M; Bagheri M; Rezaei F; Ahmadi-Abhari SA; Tabrizi M; Khalighi-Sigaroudi F; Akhondzadeh S
    Psychopharmacology (Berl); 2012 Apr; 220(3):591-8. PubMed ID: 21947320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.
    Turner DC; Clark L; Pomarol-Clotet E; McKenna P; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1363-73. PubMed ID: 15085092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
    Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
    Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
    Bobo WV; Woodward ND; Sim MY; Jayathilake K; Meltzer HY
    Schizophr Res; 2011 Aug; 130(1-3):106-13. PubMed ID: 21641776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Plebani JG; Pettinati HM; Sparkman T; O'Brien CP
    J Subst Abuse Treat; 2012 Oct; 43(3):303-12. PubMed ID: 22377391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intractability of Deficit Syndrome of Schizophrenia Against Adjunctive Modafinil.
    Shoja Shafti S; Akbari S
    J Clin Psychopharmacol; 2016 Feb; 36(1):45-9. PubMed ID: 26658259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the effects of modafinil on cognition in schizophrenia.
    Morein-Zamir S; Turner DC; Sahakian BJ
    Schizophr Bull; 2007 Nov; 33(6):1298-306. PubMed ID: 17634412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia.
    Fisher M; Loewy R; Carter C; Lee A; Ragland JD; Niendam T; Schlosser D; Pham L; Miskovich T; Vinogradov S
    Schizophr Bull; 2015 Jan; 41(1):250-8. PubMed ID: 24444862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised, observer-blinded multi-centre clinical trial.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Forchhammer HB; Melau M; Gluud C; Nordentoft M
    Trials; 2011 Feb; 12():35. PubMed ID: 21306612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.
    Keefe RS; Meltzer HA; Dgetluck N; Gawryl M; Koenig G; Moebius HJ; Lombardo I; Hilt DC
    Neuropsychopharmacology; 2015 Dec; 40(13):3053-60. PubMed ID: 26089183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.
    Kalechstein AD; Mahoney JJ; Yoon JH; Bennett R; De la Garza R
    Neuropharmacology; 2013 Jan; 64():472-8. PubMed ID: 22796108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial.
    Lillicrap T; Krishnamurthy V; Attia J; Nilsson M; Levi CR; Parsons MW; Bivard A
    Trials; 2016 Aug; 17(1):410. PubMed ID: 27534856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.